Isolated REM-sleep behavior disorder is a condition that can provide an indication of Parkinson's disease well in advance. A research team headed by Professor Dr. Erdem Gültekin Tamgüney from Heinrich Heine University Düsseldorf ...
Feb 16, 2023
0
41
When we daydream or revisit memories, a large group of regions within our brain "lights up," or becomes more active. It's referred to as the Default Mode Network (DMN) because it is more active when the brain is not focused ...
Feb 15, 2023
0
107
New findings from investigators at Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, contradict previous notions about sugar's role in the onset of diabetic cataracts. Using an ...
Jan 25, 2023
0
13
Artificial intelligence (AI) draws inspiration from current knowledge of the human brain, artificially replicating some of its learning processes and functions. The extent to which artificial agents successfully emulate the ...
Radioactivity can save lives. When neither chemotherapy nor surgery nor radiation from the outside help against a tumor, modern medicine uses so-called radiopharmaceuticals. These radioactive drugs not only detect cancer ...
Jan 9, 2023
1
68
In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...
Dec 27, 2022
0
107
A probiotic bacterium called Lacticaseibacillus rhamnosus HA-114 prevents neurodegeneration in the C. elegans worm, an animal model used to study amyotrophic lateral sclerosis (ALS).
Dec 20, 2022
0
2626
An altered gut microbiome is an unexpected cause of fever afflicting many patients undergoing chemotherapy, according to scientists who've also discovered that poor appetite during cancer treatment may trigger the biological ...
An experimental therapy has shown promise in preclinical models as treatment for an aggressively spreading type of colorectal cancer, according to a new study by Weill Cornell Medicine investigators.
Dec 15, 2022
0
51
An international research team led by Dr. Ana Guadaño at the Alberto Sols Biomedical Research Institute (IIBM, a combined CSIC-UAM center) and involving the Complutense University of Madrid (UCM), used CRISPR gene editing ...
Dec 12, 2022
0
4
